Speakers

SickBoy

SickBoy

Kick-off Keynote

Biography

The three guys who make up Sickboy – Jeremie Saunders, Taylor Macgillivary and Brian Stever – are hilarious, ridiculously insightful and determined to break down the stigmas associated with illness and disease. Sickboy began because they recognized that when faced with difficult situations, illnesses and diseases, people tighten up, get awkward, and simply don’t know what to say. Taking the lead from Jeremie’s life long battle with Cystic Fibrosis, they help people understand that sometimes the best way to deal with illness, disease and life is simply to laugh. Through the therapy of laughter, we can begin to understand that whether sick or healthy, we’re all human, and we’re all dying, so let’s talk about it.

It started in a public library recording room, moved into their own recording studio, was funded by a hugely successful Kickstarter campaign and within weeks they were among the top rated podcasts in the country. Their talks are engaging, forward thinking and hilarious. Let them inspire your audience and blow the conversation wide open today!

BioInnovation Challenge

Host – Dr. Stephen Graham

Host – Dr. Stephen Graham

CEO, Picomole Inc. and Winner of BIC 2018

For the past four years Dr. Steve Graham has worked with Picomole as an Advisor responsible for Research and Business Development and in May of 2018 was appointed CEO. During this period, Picomole has successfully recapitalized to restart its operations, developed its research program to the point where they have shown, in a clinical study, significant accuracy in detecting lung cancer using a breath test and are currently building new generation technology and planning regulatory clearance of their technology into the USA, Canada,and Europe.Steve is a Pharmacist and Epidemiologist by training. Before joining Picomole he spent eight years in the Medical Divisions of two multinational pharma companies. He has been the Principal of his own Health Outcomes Consulting business since 2002. He is retired from the RCAF where he served as an Air Navigator and laterally as a Military Pharmacist.Steve currently lives in Bedford, NS with his wife and three children.

Arif Aziz, PhD

Arif Aziz, PhD

SeniorManager, National Life Science SR&ED, MNP

Arif Aziz is a Senior Manager leading MNP’s National Life Science SR&ED practice. Drawing on more than 10 years of experience in assisting companies obtain research funding to develop and commercialize new products and technologies, Arif helps clients understand the underlying research endeavor and how it relates to the SR&ED program and their business context to ensure clients realize maximally beneficial claims. He also helps organizations with general business strategy and commercialization of newly developed products and services in the life science sector.With deep knowledge and experience in SR&ED, business strategy, and commercialization Arif develops practical solutions and delivers results for his clients. His cross-industry expertise includes biotechnology, medical devices,pharmaceuticals, digital health, and professional services.Prior to starting his consulting career he was a postdoctoral fellow at the Ottawa Hospital Research Institute.

Milos Todorovic, Ph.D.

Milos Todorovic, Ph.D.

International Business Development Officer, Global Affairs Canada

As the International Business Development Officer for Life Sciences, Milos leverages relationships with leading innovators, corporate leaders, and investors to facilitate business and research collaborations between the Canadian and U.S. pharmaceutical, biotech, and medical devices companies. Milos is a highly analytical health tech professional with close to 20 years of experience in business development,R&D, tech scouting, and strategic advisory roles. His extensive background in technology and business development in global work settings enables him to quickly and comprehensively assess new technology and business opportunities from a unique client-centric perspective. Prior to joining the Global Affairs Canada, Milos founded and managed MT Analytics Group, a boutique technology intelligence and consulting firm helping global clients to navigate the rapidly changing health care landscape. Before that, he was a health technologies practice leader with Lux Research and a project leader and biomedical systems designer with GE Global Research. Milos received his Ph.D. in Biomedical Engineering from Texas A&M University.

Jennifer Hamilton, PhD

Jennifer Hamilton, PhD

Senior Director, New Ventures at Johnson & Johnson Innovation and Advisor to Johnson & Johnson’s Impact Investing team

Jennifer has worked with J&J scouting new technology opportunities in Canada since 2010. Prior to working with J&J, Jennifer spent 17 years in venture capital as Venture Partner at UK-based Nomura Phase4 Ventures and an Investment Director with Rothschild Asset Management. She has also worked as an advisor to early and late-stage companies, venture funds and pension funds giving financing,business development, and M&A advice. Jennifer has an MSc and a PhD in Experimental Pathology/Lipid Metabolism from the University of British Columbia and a BSc from the University of Guelph.

BIC Junior

Rob Henderson

Rob Henderson

President and CEO, BioTalent Canada

Rob Henderson President & CEO, BioTalent Canada Rob Henderson is the President and CEO of BioTalent Canada, the HR partner of and a catalyst for growth in Canada’s bio-economy. The organization’s engagement with employers, associations, post-secondary institutions, immigrant serving agencies,and service providers has built a dynamic network that is strengthening skills, connecting job-ready talent to industry and creating opportunities. The organization has along and successful track record of implementing wage subsidies, HR products and labour market information to assist companies in recruiting the talent they need. Mr. Henderson holds a BSc Honours in Biology from the University of Ottawa and possesses more than 25 years of senior management experience in the private and public sectors. His expertise and experience have now been extending to the Labour Market Information Council as a member of their National Stakeholders Advisory Panel.

Kristin Tweel, PhD

Kristin Tweel, PhD

Business Development Officer, Genome Atlantic

As a BDO, Kristin helps companies assess potential genomics-based approaches and works with teams to deliver competitive research proposals. While Kristin loves talking science with the research community,she has a great ability to translate that scientific passion into real-world applications for industry and the public sector. Focused on a portfolio of mining, the environment,and health, you’ll most likely find Kristin connecting companies and researchers from these areas, helping them understand each other’s worlds to address challenges like clean drinking water, bioremediation, and rare diseases.Kristin obtained her Ph.D in Pharmacology from Dalhousie in 2011 where her research focused on the solid tumor microenvironment in colorectal cancer models. She then completed an MBA at Saint Mary’s University in 2014, during which time she interned with PEI biotech company, BioVectra, where, among other things, she developed an evaluation model to assess risks and opportunities for generic drug development. In her spare time, Kristin has volunteered for the Mende Nazer Foundation, a judge for the Discovery Centre Awards, and practices Brazilian Jiu Jitsu

Kathleen Allen

Kathleen Allen

Manager, Assurance and Business Advisory , MNP

Kathleen Allen is a Manager in MNP’s Assurance and Advisory practice. Kathleen delivers a full suite of assurance, accounting, and advisory services to clients across a variety of industries. She draws on her knowledge and skill to embrace the new and exciting challenges that her profession offers and helps to ensure clients are able to embrace new and exciting opportunities as they arise. Kathleen received her Bachelor of Commerce degree from Saint Mary’s University’s Sobey School of Business in 2012. Two years later, she became a Chartered Professional Accountant (CPA), qualifying as a Chartered Accountant (CA). Kathleen also holds the Certified Internal Auditor (CIA) designation. Kathleen is a volunteer board member for the Centre of Entrepreneurship & Educational Development(CEED).

Growing our Health and Life Sciences Sector (Fireside Chat)

How can industry align its interests with the interests of government, academia and research to develop a health and life sciences sector that drives economic development? In this fireside chat we will learn about effective activities, initiatives and strategies that will foster entrepreneurship and innovation – driving economic growth. Join us as we talk to trailblazers and industry leaders about the opportunities and challenges of building a globally competitive health and life sciences sector.

Moderator

Scott Moffitt

Scott Moffitt

Executive Director, BioNova

Scott is a senior management professional with more than 20 years of life science experience in industry, government and non-profit sectors.  By leveraging his leadership and management abilities, Scott has built solid relationships and delivered significant results in each position he has held.  Having returned to his home province a few years ago, Scott is now focused on making Nova Scotia a better place.

Scott is presently the Managing Director of BioNova, Nova Scotia’s life sciences and biotechnology industry association and sector development organization, where he is leading the advancement of the sector for the Province of Nova Scotia to establish the life sciences as a pillar of the new economy.  Scott leads a team focussed on building collaborative relationships within the province and beyond to attract companies, investment and people to Nova Scotia.

Scott served most recently as the Senior Investment Officer – Bioscience, for Innovation PEI, the lead economic development agency for the Province of Prince Edward Island.  In this position, Scott led a team of professionals and was responsible for the growth of the bioscience sector through prospecting, attracting and investing in international businesses, and by internal business growth of on-island companies

Among his significant previous positions, Scott was the commercialization officer with BioNova, assisting early stage companies with their business development efforts, offering strategic business and industry advice to accelerate commercial development and build value.  Prior to this, Scott served as the marketing manager for the microbiology division of Thermo Fisher Scientific, where he was responsible for overall market development, the introduction of innovative strategies and the management of supplier partners for the Canadian marketplace.  Before being recruited to the microbiology division, he was the business development marketing manager for Thermo Fisher Scientific and was responsible for attracting, introducing and managing new suppliers to expand the existing distribution capabilities within Canada.

Scott has Bachelor and Master of Science degrees from Acadia University and presently resides in Halifax, NS with his family.

Brian Lewis

Brian Lewis

President and CEO, MEDEC

Brian Lewis is the President & CEO of MEDEC, the Canadian association
representing the medical technology industry and diagnostic companies across
Canada.
Prior to joining in 2012 Brian worked for Genzyme Canada from May 2005 till
Dec 2012 as General Manager, where he was responsible for strategic
direction and operations.
He brought extensive leadership experience to Genzyme, having held
progressive management positions at Hoechst Marion Roussel, Serono, and
AstraZeneca Canada,
Mr. Lewis has a Bachelor of Science in Human Kinetics from the University of
Guelph and a Bachelor of Business Administration from York University.

The Future of Personalized Health & Human Performance (Panel Session)

Sponsored by Genome Atlantic
Personalized approaches in the healthcare space and data analytics are revolutionizing the way we view and manage our health. Enhancements in genomic testing, technology and health data are unlocking predictors of health, disease and even human performance. Join us as we talk to industry trailblazers about the ecosystem of personalized healthcare, wellness and human performance in the region and the impacts for business, patients, clinicians, researchers and our health system.

Moderator

Steve Armstrong, PhD

Steve Armstrong, PhD

President & CEO, Genome Atlantic
Travis McDonough

Travis McDonough

Founder & CEO, Kinduct

Travis McDonough is the founder and CEO of Kinduct–an Athlete Management System that consolidates medical and performance data for some of the world’s biggest and best-known professional sports teams, universities, brands, and Olympic Committees. Travis holds a Bachelor of Science degree in Kinesiology from Dalhousie University and a Doctor of Chiropractic degree. A health care practitioner, Travis has dedicated his entire career to his passion for sparking innovation and driving constant improvement in the sport, health, and wellness industries. His work in these fields has been widely recognized, earning numerous awards including Atlantic Canada’s Innovator of the Year, Halifax Business Person of the Year, Atlantic Business Magazine Top 50 CEOs (inducted into Hall of Fame in 2018), ITAC Ingenious Award, and The Experiential Learning Award via Game Changers Awards and the Halifax Partnership.Outside of Kinduct, Travis finds many ways to give back to his community through coaching, serving on various boards,and mentoring other sport tech startups. Travis enjoys spending family time at his cottage with his three children and wife, Margaret Taylor

Dr. Janessa Laskin

Dr. Janessa Laskin

Associate Professor, Department of Medicine, University of British Columbia Oncologist, BC Cancer Agency

Dr. Laskin is a clinical Associate Professor in the Department of Medicine at the University of British Columbia and an active member of the medical oncology staff at BC Cancer Agency in Vancouver,Canada. Her clinical and research interests have primarily focused on lung, head, and neck cancers. She is an active member of many national and international lung cancer trials and advisory groups. In the last seven years her research has evolved toward cancer genomics and personalized medicine and she is the clinical program leader for the Personalized Oncogenomics (POG) Program which is a collaborative research project between medical oncologists and the Michael Smith Genome Sciences Centre in Vancouver. The POG program is truly translational research effort that uses in-depth genomic and transcriptomic sequencing to guide chemotherapy decision-making in a clinically relevant time-frame

Dr. Chris McMaster

Dr. Chris McMaster

Scientific Director, Canadian Institutes of Health Research Professor of Pharmacology, Faculty of Medicine, Dalhousie University CEO, DeNovaMed Inc.
Dr. Christopher McMaster, PhD, is the Scientific Director of the Institute of Genetics for the Canadian Institutes of Health Research, Professor of Pharmacology in the Faculty of Medicine at Dalhousie University, and CEO of DeNovaMed Inc. Previously, he was the Carnegie and Rockefeller Professor and Head of Pharmacology at Dalhousie University, and was the Assistant Dean for Graduate and Post-doctoral Studies in the Faculty of Medicine at Dalhousie University. He held a Canada Research Chair(Tier 2) in Biosignalling. Dr. McMaster’s main research interest is treatments for inherited and infectious diseases. As a researcher, he is a leader in genetics, biochemistry, and cell biology. His research is broad in interest ranging from basic biochemistry and cell biology, to genomics to determine causal genes for human genetic diseases and their amelioration, to ethical and policy considerations as human genomics is being transitioned toward clinical diagnosis and care. Since 2010, he has been a PI or co-PI on over $40 million in research and development grants, with over $30 million directed toward his home institution of Dalhousie University. He has led, and currently leads, large research consortia including acting as PIon a Genome Canada large scale applied research project, as PI on several CIHR grants, as PI on a large-scale Atlantic Innovation Fund project, and as co-PI on a large Canada Foundation for Innovation grant. Dr. McMaster has identified several human genes and their functions, including many associated with inherited human disease. His work on therapeutics has resulted in a potential therapy for congenital sideroblastic anemia, and has lead compounds undergoing development for the treatment of the inherited blinding disorder familial exudative vitreoretinopathy, inherited Parkinson’s disease, and a form of muscular dystrophy. In 2006, Dr. McMaster co-founded DeNovaMed Inc, a Halifax based biotechnology company focused on bringing new medicines to the clinic/market to treat drug resistant bacteria-the so-called superbugs. DeNovaMed has candidate compounds for both Gram negative and positive bacteria that are in the pre-IND approval process stage.

Tapping into Atlantic Canada’s Natural Resource Economy (Panel)

How can we can leverage our bio-resources in oceans, forestry and agriculture sustainably to build high-value products such as, medicines, nutritional supplements and eco-friendly products to drive global innovation regionally. Join us as we talk to regional industry leaders who are transforming natural resources into billion-dollar business opportunities that are tackling global markets.

Moderator

Dr. Roberto Armenta

Dr. Roberto Armenta

Chief Scientist and Director of R&D, Mara Renewables Corporation

Dr.Roberto Armenta is the Chief Scientist and Director of Research & Development of Mara Renewables Corporation. Dr. Armenta has worked extensively in academic, government,and industrial sectors. His work includes R&D on industrial biochemical processes, and his research has been crucial in developing novel processes for the development of microbial bio-products. With over 15 years’ experience, Armenta’s tenures have included roles as Natural Product Biochemist with the Prince Edward Island government and Senior Scientist, Director of R&D for Ocean Nutrition Canada Limited (ONC)’s Fermentation and Metabolic Engineering Group. He’s an Adjunct Professor in the Department of Process Engineering and Applied Sciences at Dalhousie University and a prolific inventor and author, with over a dozen commercial patents and numerous peer-reviewed scientific publications to his name. He’s also a member of the Society for Industrial Microbiology and Biotechnology and the American Oil Chemists’Society. He works, and lives happily with his family, in Dartmouth, Nova Scotia.

TJ Galiardi

TJ Galiardi

Co-Founder & CMO, Beyond Food Inc

TJ Galiardi is the current Co-Founder and CMO of Beyond Food, a Canadian company tackling food waste by upcycling produce that would normally be lost in the grocer and farm supply chain. Before his time at Beyond Food, TJ played professional hockey for 10 years, including 7 seasons in the NHL. Galiardi was drafted in the second round, 55th overall in the 2007 NHL Entry Level Draft by the Colorado Avalanche, he also went on to play for the San Jose Sharks, Calgary Flames and Winnipeg Jets. Prior to the draft he played for the Calgary Hitmen in the WHL and Ivy League school Dartmouth College in the ECAC where he studied economics and art. TJ was born in Calgary, Alberta but holds dual citizenship in the US as his mother was born in Arizona. Galiardi lives in Halifax, Nova Scotia with his wife Paulina and their daughter Sage.

Ryan Duff

Ryan Duff

Senior Consultant, BioApplied Innovation Pathways & Nova Scotia Innovation Hub

Ryan Duff is a Senior Consultant with BioApplied Innovation Pathways, a boutique consulting firm providing business development, market intelligence, and project management services to the bio-resource sector, supporting companies on their path to commercialization. BioApplied works to deliver innovation throughout the bio-resource supply chain, from feed stock to end consumer.A key client for BioApplied is the Nova Scotia Innovation Hub (NSIH), whose missions is to support and grow Nova Scotia’s bio-resource sector, promoting the province as a leader in providing low-carbon solutions to the global marketplace, while enhancing economic prosperity. The NSIH provides project funding, engages with bio-resource companies across the globe and facilitates project execution within Nova Scotia.Ryan is constantly striving to combine business with environmental sustainability, and he does this by helping to bring products made from renewable resources to market. He has over 10 years of experience in a variety of fields, including banking, economic consulting, environmental non-profits, and renewable resource product and business development. He holds a Bachelor of Commerce degree in Finance from Dalhousie University, as well as a Master’s degree in Development Economics, with a focus on Environmental Economics, also from Dalhousie.

Jaouad Fichtali

VP R&D - Human & Animal Health, Acadian Seaplants

Great Things are Happening Here (Interview)

Senior industry healthcare executive Pam Winsor will discuss why she thinks the regional health and life sciences community is filled with trailblazers.

Interviewer – Paul Bradley

Interviewer – Paul Bradley

President, MedTech Consulting Inc. Former VP of Strategic Affairs, Johnson & Johnson
Paul Bradley is a healthcare industry executive with over 30 years experience in the Canadian medical device and pharmaceutical markets. He has held leadership roles in a wide range of functional areas at Johnson & Johnson including sales, marketing, strategic account management, human resources, and operations. As Vice President of Strategic Affairs Paul had leadership responsibility for health economics and market access, professional education, clinical and regulatory affairs, quality, health care compliance, and was a member of the Management Board. Paul is also a leader within the Canadian medical device industry, serving on the MEDEC Board from 2009 to 2016 holding various leadership roles over that time including Treasurer, Executive Team Member, and Board Chair for the final two years. Paul is currently a Board member and Treasurer at ventureLAB, York Region’s Regional Innovation Centre, and is a member of the Ontario Health Technology Advisory Committee (OHTAC). Paul is President of MedTech Consulting where he works with small and medium sized companies in the area of business development.
Pamela Winsor, RN, MBA, ICD.D

Pamela Winsor, RN, MBA, ICD.D

Retired, Former Executive with Medtronic

Pam is a well-respected and highly accomplished healthcare leader in Canada.With 20+ years as a Senior Healthcare Executive, Pam has a deep knowledge of the life sciences sector and what it takes to get a new technology or solution to market and fully funded, in a very restrained healthcare environment. More importantly, Pam has expertise in the future direction of healthcare-value-based healthcare strategies and novel access approaches which improve outcomes and lower costs. This will encompass new players/technologies, new financial models and more long-term strategic oversight, challenging legacy care models,and current healthcare boards. Pam did her eMBA (2000) and ICD.D (2015) at St. Mary’s University in Halifax. In addition to these academic credentials, Pam is a Rotman, Judy Project Alumni,and an executive coach. Since stepping down from a very fulfilling executive career at Medtronic Canada in May 2019, Pam is an active Board Director and is an Atlantic Canada Ambassador for Women get on Board (WGOB).